P

PureIMS

9 employees

PureIMS provides dry powder inhalation, compounding clinical trial medication, compounding pharmacy, and pulmonary administration services.

Basic info

Industry

pharmaceutical manufacturing

Sectors

Biotechnology
Life Science
Development of dry powder inhalers
Cystic Fibrosis
Clinical Trials
Compounding clinical trial medication
Dry powder inhalation
Compounding pharmacy
Infectious diseases
Pulmonary administration
Tuberculosis
Parkinson disease
Clinical trials

Date founded

2014

Funding rounds raised

P

PureIMS raised undisclosed on April 3, 2023

Investors: Carduso Capital B.V and Balsz Elementary School

FAQ